Correlation of NPDC1 Expression and Perineural Invasion Status with Clinicopathological Features in Patients with Colon Cancer

References

• Hayden DM. Surgical approaches to locally advanced colon cancer: best approach is a tough question to answer. Surgery. 2021;170(6):1616–1617. doi:10.1016/j.surg.2021.09.007
   PubMed Web of Science ®Google Scholar
• Verkuijl SJ, Jonker JE, Trzpis M, Burgerhof JGM, Broens PMA, Furnée EJB. Functional outcomes of surgery for colon cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2021;47(5):960–969. doi:10.1016/j.ejso.2020.11.136
   PubMed Web of Science ®Google Scholar
• Li J, Kang R, Tang D. Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma. Cancer Commun. 2021;41(8):642–660. doi:10.1002/cac2.12188
   Web of Science ®Google Scholar
• Yang MW, Tao LY, Jiang YS, et al. Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma. Cancer Res. 2020;80(10):1991–2003. doi:10.1158/0008-5472.Can-19-2689
   PubMed Web of Science ®Google Scholar
• Spencer ML, Theodosiou M, Noonan DJ. Npdc-1, a novel regulator of neuronal proliferation, is degraded by the ubiquitin/proteasome system through a pest degradation motif. J Biol Chem. 2004;279(35):37069–37078. doi:10.1074/jbc.M402507200
   PubMed Web of Science ®Google Scholar
• Evrard C, Caron S, Rouget P. Functional analysis of the Npdc-1 gene. Gene. 2004;343(1):153–163. doi:10.1016/j.gene.2004.08.020
   PubMed Web of Science ®Google Scholar
• Gao H, Ni N, Zhang D, et al. Mir-762 regulates the proliferation and differentiation of retinal progenitor cells by targeting Npdc1. Cell Cycle. 2020;19(14):1754–1767. doi:10.1080/15384101.2020.1777805
   PubMed Web of Science ®Google Scholar
• Lin-Moore AT, Oyeyemi MJ, Hammarlund M, Copenhaver GP. Rab-27 acts in an intestinal pathway to inhibit axon regeneration in C. Elegans. PLoS Genet. 2021;17(11):e1009877. doi:10.1371/journal.pgen.1009877
   PubMed Web of Science ®Google Scholar
• Chen SH, Zhang BY, Zhou B, Zhu CZ, Sun LQ, Feng YJ. Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche. Am J Cancer Res. 2019;9(1):1–21.
   PubMed Web of Science ®Google Scholar
• Cienfuegos JA, Martínez P, Baixauli J, et al. Perineural invasion is a major prognostic and predictive factor of response to adjuvant chemotherapy in stage I-II colon cancer. Ann Surg Oncol. 2017;24(4):1077–1084. doi:10.1245/s10434-016-5561-0
   PubMed Web of Science ®Google Scholar
• Kang JH, Son IT, Kim BC, Park JH, Kim JY, Kim JW. Recurrence-free survival outcomes based on novel classification combining lymphovascular invasion, perineural invasion, and T4 status in stage II-III colon cancer. Cancer Manag Res. 2022;14:2031–2040. doi:10.2147/cmar.S358939
   PubMed Web of Science ®Google Scholar
• Liu Q, Ma Z, Cao Q, et al. Perineural invasion-associated biomarkers for tumor development. Biomed Pharmacother. 2022;155:113691. doi:10.1016/j.biopha.2022.113691
   PubMed Web of Science ®Google Scholar
• Chen CI, Li WS, Chen HP, et al. High expression of folate receptor alpha (Folr1) is associated with aggressive tumor behavior, poor response to chemoradiotherapy, and worse survival in rectal cancer. Technol Cancer Res Treat. 2022;21:15330338221141795. doi:10.1177/15330338221141795
   Web of Science ®Google Scholar
• Huang H-C, Shiu B-H, Su S-C, et al. The impact of matrix metalloproteinase-11 polymorphisms on colorectal cancer progression and clinicopathological characteristics. Diagnostics. 2022;12(7):1685. doi:10.3390/diagnostics12071685
   Web of Science ®Google Scholar
• Nie Q, Peng WW, Wang Y, Zhong L, Zhang X, Zeng L. Β-catenin correlates with the progression of colon cancers and berberine inhibits the proliferation of colon cancer cells by regulating the Β-catenin signaling pathway. Gene. 2022;818:146207. doi:10.1016/j.gene.2022.146207
   PubMed Web of Science ®Google Scholar
• Ngamkham J, Thuwajit C, Thuwajit P, et al. Overexpression of pyruvate carboxylase is correlated with colorectal cancer progression and supports growth of invasive colon cancer Ht-29 cell line. Anticancer Res. 2020;40(11):6285–6293. doi:10.21873/anticanres.14649
   PubMed Web of Science ®Google Scholar
• Zeng Z, Yang H, Xiao S. Actl6a expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer. BMC Cancer. 2018;18(1):1020. doi:10.1186/s12885-018-4931-3
   PubMed Web of Science ®Google Scholar
• Modhukur V, Iljasenko T, Metsalu T, Lokk K, Laisk-Podar T, Vilo J. Methsurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics. 2018;10(3):277–288. doi:10.2217/epi-2017-0118
   PubMed Web of Science ®Google Scholar
• Anuraga G, Wang WJ, Phan NN, et al. Potential prognostic biomarkers of nima (Never in Mitosis, Gene a)-related kinase (Nek) family members in breast cancer. J Pers Med. 2021;11(11):1089. doi:10.3390/jpm11111089
   PubMed Web of Science ®Google Scholar
• Xing C, Wang Z, Zhu Y, et al. Integrate analysis of the promote function of cell division cycle-associated protein family to pancreatic adenocarcinoma. Int J Med Sci. 2021;18(3):672–684. doi:10.7150/ijms.53243
   PubMed Web of Science ®Google Scholar
• Barretina J, Caponigro G, Stransky N, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603–607. doi:10.1038/nature11003
   PubMed Web of Science ®Google Scholar
• Kao TJ, Wu CC, Phan NN, et al. Prognoses and genomic analyses of proteasome 26s subunit, atpase (Psmc) family genes in clinical breast cancer. Aging. 2021;13(14):17970. doi:10.18632/aging.203345
   PubMedGoogle Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. Gepia: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–w102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The Cbio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404. doi:10.1158/2159-8290.Cd-12-0095
   PubMed Web of Science ®Google Scholar
• Liu J, Huang X, Liu H, et al. Immune landscape and prognostic immune-related genes in kras-mutant colorectal cancer patients. J Transl Med. 2021;19(1):27. doi:10.1186/s12967-020-02638-9
   PubMed Web of Science ®Google Scholar
• Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape stringapp: network analysis and visualization of proteomics data. J Proteome Res. 2019;18(2):623–632. doi:10.1021/acs.jproteome.8b00702
   PubMed Web of Science ®Google Scholar
• Yin X, Wu Q, Hao Z, Chen L. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis. Biomed Eng Online. 2022;21(1):26. doi:10.1186/s12938-022-00995-8
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lin E, Zhuang H, et al. Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma. Cancer Cell Int. 2020;20(1):27. doi:10.1186/s12935-020-1113-6
   PubMed Web of Science ®Google Scholar
• Lin W, Wu S, Chen X, et al. Characterization of hypoxia signature to evaluate the tumor immune microenvironment and predict prognosis in glioma groups. Front Oncol. 2020;10:796. doi:10.3389/fonc.2020.00796
   PubMed Web of Science ®Google Scholar
• Cao L, Sun PL, Yao M, Jia M, Gao H. Expression of Yes-Associated Protein (Yap) and its clinical significance in breast cancer tissues. Hum Pathol. 2017;68:166–174. doi:10.1016/j.humpath.2017.08.032
   PubMed Web of Science ®Google Scholar
• Conte GA, Qari O, Fasano GA, et al. S100 staining adds to the prognostic significance of the combination of perineural invasion and lymphovascular invasion in colorectal cancer. Appl Immunohistochem Mol Morphol. 2020;28(5):354–359. doi:10.1097/pai.0000000000000733
   PubMedGoogle Scholar
• White M, Foulis AK, Smith G, Horgan PG, Roxburgh CS. The role of S100 staining in the pathological assessment of perineural invasion in rectal cancer. Colorectal Dis. 2014;16(1):71–72. doi:10.1111/codi.12471
   PubMed Web of Science ®Google Scholar
• Panicker RC, Chattopadhaya S, Coyne AG, Srinivasan R. Allosteric small-molecule serine/threonine kinase inhibitors. Adv Exp Med Biol. 2019;1163:253–278. doi:10.1007/978-981-13-8719-7_11
   PubMed Web of Science ®Google Scholar
• Panchal NK, Evan Prince S. The nek family of serine/threonine kinases as a biomarker for cancer. Clin Exp Med. 2023;23(1):17–30. doi:10.1007/s10238-021-00782-0
   PubMed Web of Science ®Google Scholar
• Gyparaki MT, Basdra EK, Papavassiliou AG. DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer. J Mol Med. 2013;91(11):1249–1256. doi:10.1007/s00109-013-1088-z
   PubMed Web of Science ®Google Scholar
• Li LT, Jiang G, Chen Q, Zheng JN. Ki67 is a promising molecular target in the diagnosis of cancer (Review). Mol Med Rep. 2015;11(3):1566–1572. doi:10.3892/mmr.2014.2914
   PubMed Web of Science ®Google Scholar
• Väyrynen SA, Väyrynen JP, Klintrup K, et al. Clinical impact and network of determinants of tumour necrosis in colorectal cancer. Br J Cancer. 2016;114(12):1334–1342. doi:10.1038/bjc.2016.128
   PubMed Web of Science ®Google Scholar
• Lugli A, Zlobec I, Berger MD, Kirsch R, Nagtegaal ID. Tumour budding in solid cancers. Nat Rev Clin Oncol. 2021;18(2):101–115. doi:10.1038/s41571-020-0422-y
   PubMed Web of Science ®Google Scholar